Literature DB >> 9263871

Perioperative morbidity and mortality in combined aortic and mitral valve surgery.

X M Mueller1, H T Tevaearai, P Ruchat, M Hurni, A P Fischer, F Stumpe, L K von Segesser.   

Abstract

BACKGROUND AND AIMS OF THE STUDY: Despite many significant improvements in cardiac surgical technique, the operative risk for combined aortic and mitral valve surgery remains between 5% and 12%. Identification of high-risk patients will allow surgeons to develop strategies to improve these results.
METHODS: The 30-day postoperative mortality and complication rates were analyzed in a group of 206 patients operated on over a 16-year period with cold crystalloid cardioplegia. Thirty-three possible risk factors for death and low output syndrome (LOS) were entered into univariate and multivariate logistic regression analysis.
RESULTS: There were 10 perioperative deaths (4.9%). Major complications occurred in 38 patients (18.4%), 19 with LOS. On univariate analysis, right atrial pressure (RAP) > or = 8 mmHg (p = 0.001), aortic stenosis (p = 0.009) and systolic pulmonary artery pressure > or = 60 mmHg (p = 0.095) were found to be risk factors for death, as were RAP > or = 8 mmHg (p = 0.001), previous heart surgery (p = 0.007), serum creatinine > or = 120 mumol/l (p = 0.03), tricuspid valve disease (p = 0.038) and aortic stenosis (p = 0.09) for LOS. On multivariate analysis, RAP > or = 8 mmHg (p < 0.001) and aortic stenosis (p = 0.002) were identified as independent risk factors for death, as were RAP > or = 8 mmHg (p = 0.001) and previous heart surgery (p = 0.008) for LOS.
CONCLUSIONS: Mitro-aortic valve surgery involves complex procedures with substantial mortality and morbidity. The risk factors point toward the importance of operating before the stage of advanced heart failure and toward the key role of better myocardial protection techniques in these compromised hearts with limited reserves.

Entities:  

Mesh:

Year:  1997        PMID: 9263871

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  3 in total

1.  Short- and mid-term results of triple-valve surgery with an evaluation of postoperative quality of life.

Authors:  Saeed Davoodi; Abbasali Karimi; Seyed Hossein Ahmadi; Mehrab Marzban; Namvar Movahhedi; Kyomars Abbasi; Abbas Salehi Omran; Mahmood Shirzad; Mehrdad Sheikhvatan
Journal:  Tex Heart Inst J       Date:  2009

2.  Impact of cardiac comorbidities on early and 1-year outcome after percutaneous mitral valve interventions: data from the German transcatheter mitral valve interventions (TRAMI) registry.

Authors:  Carsten Schwencke; Klaudija Bijuklic; Taoufik Ouarrak; Edith Lubos; Wolfgang Schillinger; Björn Plicht; Holger Eggebrecht; Stephan Baldus; Gerhard Schymik; Peter Boekstegers; Rainer Hoffmann; Jochen Senges; Joachim Schofer
Journal:  Clin Res Cardiol       Date:  2016-10-17       Impact factor: 5.460

3.  Impact of preprocedural mitral regurgitation upon mortality after transcatheter aortic valve implantation (TAVI) for severe aortic stenosis.

Authors:  M Z Khawaja; R Williams; J Hung; S Arri; K N Asrress; K Bolter; K Wilson; C P Young; V Bapat; J Hancock; M Thomas; S Redwood
Journal:  Heart       Date:  2014-08-25       Impact factor: 5.994

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.